Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
11(31%)
Results Posted
55%(6 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_3
5
14%
Ph not_applicable
5
14%
Ph phase_4
15
43%
Ph phase_1
2
6%
Ph early_phase_1
1
3%
Ph phase_2
6
17%

Phase Distribution

3

Early Stage

6

Mid Stage

20

Late Stage

Phase Distribution34 total trials
Early Phase 1First-in-human
1(2.9%)
Phase 1Safety & dosage
2(5.9%)
Phase 2Efficacy & side effects
6(17.6%)
Phase 3Large-scale testing
5(14.7%)
Phase 4Post-market surveillance
15(44.1%)
N/ANon-phased studies
5(14.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

64.7%

11 of 17 finished

Non-Completion Rate

35.3%

6 ended early

Currently Active

11

trials recruiting

Total Trials

35

all time

Status Distribution
Active(16)
Completed(11)
Terminated(6)
Other(2)

Detailed Status

Completed11
Recruiting8
Not yet recruiting4
Withdrawn4
Active, not recruiting3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
35
Active
11
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.9%)
Phase 12 (5.9%)
Phase 26 (17.6%)
Phase 35 (14.7%)
Phase 415 (44.1%)
N/A5 (14.7%)

Trials by Status

completed1131%
not_yet_recruiting411%
active_not_recruiting39%
terminated26%
enrolling_by_invitation13%
recruiting823%
withdrawn411%
unknown26%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT05713630Phase 3

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

Recruiting
NCT06665594Phase 2

Effect of TXA on Reducing Bruising After Filler Injection

Recruiting
NCT06070350Phase 3

Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07494032Not Applicable

Extended Oral Tranexamic Acid After Primary Total Knee Arthroplasty

Not Yet Recruiting
NCT07455591Phase 4

A Trial of Intraoperative Fibrin Sealant on Postoperative Recovery After Total Knee Replacement

Completed
NCT07115056Phase 4

Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction

Withdrawn
NCT07401394Not Applicable

BAR-TAX - Tranexamic Acid in Bariatric Surgery.

Active Not Recruiting
NCT07392034Phase 2

Efficacy of Tranexamic Acid Reducing Blood Loss During Maxillofacial Trauma Surgery

Completed
NCT04803747Phase 4

A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Completed
NCT07332910Phase 4

Study the Anti-inflammatory Effect of Tranexamic Acid When Used in Anterior Cruciate Ligament Reconstruction.

Not Yet Recruiting
NCT07212452Phase 2

Tranexamic Acid : Nebulization vs IV Route for Hemoptysis

Completed
NCT03136445Phase 3

TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia

Completed
NCT07116395Phase 4

Prospective Study: TXA, Anticoagulant, Orthopaedic Trauma

Not Yet Recruiting
NCT07169383Phase 2

Oral Melatonin Versus Oral Tranexamic Acid in the Management of Melasma

Enrolling By Invitation
NCT03063892Phase 4

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

Recruiting
NCT07034560Phase 4

Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma

Active Not Recruiting
NCT07002749Phase 1

ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS

Not Yet Recruiting
NCT04347122Phase 4

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

Terminated
NCT06879353Not Applicable

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Completed

Drug Details

Intervention Type
DRUG
Total Trials
35